Edluar Side Effects

Although most people do not experience problems with Edluar, side effects are possible. Some of the most commonly reported reactions to this sleep aid include dizziness, drowsiness, and headaches. While most side effects are mild and do not require medical attention, you should contact your healthcare provider right away if you experience chest pain, memory loss, or anxiety.

An Introduction to Edluar Side Effects

Just like any medicine, Edluar™ (zolpidem sublingual tablet) can cause side effects. However, not everyone who takes the drug will have problems. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can be treated easily by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with Edluar. Your healthcare provider can discuss a more complete list of Edluar side effects with you.)
 

Common Side Effects of Edluar

Zolpidem (the active ingredient in Edluar) has been studied extensively in clinical trials. In these studies, side effects occurring in the group of people taking zolpidem were documented and compared to those that occurred in a similar group of people taking a placebo (a "sugar pill" with no active ingredients).
 
Based on these studies, the most common bothersome (but usually not dangerous) side effects of Edluar included:
 
  • Drowsiness (presumably undesirable daytime drowsiness) -- in up to 8 percent of people
  • Headaches -- up to 7 percent
  • Dizziness -- up to 5 percent
  • Sinus infection or inflammation -- up to 4 percent.
     
Other common reactions (occurring in 1 to 3 percent of people) included:
 
  • A drugged feeling
  • Flu-like symptoms (such as a fever or chills)
  • Lightheadedness
  • Abnormal dreams
  • Sleeping problems
  • Dry mouth
  • Back pain
  • Lethargy
  • Diarrhea
  • Constipation
  • Sore throat.
(Edluar Side Effects Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation